PremiumCompany AnnouncementsTecan Group AG Earnings Call: Mixed Outlook Amid Innovations Tecan downgraded to Hold from Buy at Deutsche Bank Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations PremiumThe FlyTecan downgraded to Hold from Buy at Kepler Cheuvreux Tecan price target lowered to CHF 259 from CHF 300 at Morgan Stanley Tecan price target lowered to CHF 328 from CHF 400 at Berenberg PremiumThe FlyTecan price target raised to CHF 311 from CHF 300 at Morgan Stanley Tecan downgraded to Add from Buy at Baader Helvea Tecan initiated with an Equal Weight at Morgan Stanley 
